FOXA1: function and regulation of pioneer factors

FOXA1 is a protein that acts like a master key, unlocking specific genes that turn healthy cells into hormone-driven cancers such as breast or prostate cancer, yet scientists do not know exactly how it works or what controls it. This matters because FOXA1 is the archetypal "pioneer factor"—a specialised protein that decides which genes a cell will use to define its identity. In hormone-dependent cancers, FOXA1 helps cancer cells grow and spread, but the molecular machinery that switches FOXA1 on and off, and the specific parts of the protein required for its activity, remain largely unknown. Without this knowledge, researchers cannot design drugs that precisely target FOXA1 without disrupting other essential cellular processes. If this research succeeds, it will reveal the exact amino acids FOXA1 needs to function and identify the upstream proteins that regulate its stability. The team will also build a new method to discover pioneer factors from any cell type. This could eventually lead to more targeted cancer therapies that block FOXA1's activity in tumours while sparing healthy tissue. The work is fundamental science—it does not promise an immediate treatment—but understanding how pioneer factors work has historically opened doors to entirely new classes of drugs, such as those that disrupt protein-protein interactions in cancer cells.